• SENSEX
    NIFTY 50
Business

US FDA red flags Glenmark over batch failure investigations at Baddi facility

Updated : October 17, 2019 08:16 AM IST

The US health regulator has red-flagged Glenmark Pharmaceuticals for failing to thoroughly investigate violation of manufacturing norms and implement corrective action at its Baddi plant in Himachal Pradesh.
The US FDA also warned the firm that until it corrects all violations, it may withhold approval of new drug applications from the plant.
US FDA red flags Glenmark over batch failure investigations at Baddi facility

You May Also Like

Live TV
Advertisement